MOPP regimen
2-chloro-N-(2-chloroethyl)-N-methylethanamine;(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione;methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-5-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-6-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate;4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide
Molecular Identity
MOPP regimen
2-chloro-N-(2-chloroethyl)-N-methylethanamine;(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione;methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-5-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-6-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2(7),3,5,13-tetraene-10-carboxylate;4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide
PubChem CID: 56842198
2D Structure
Properties
C84H112Cl2N8O16
Molecular Formula
1560.70
Molecular Weight
g/mol
1558.7573
Exact Mass
Da
319
TPSA
May have limited oral absorption
8
H-Bond Donors
21
H-Bond Acceptors
2770
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(5)
MOPP regimenMustargen-Oncovin-Procarbazine-Prednisone regimenC014553000Mustargen / Oncovin / Procarbazine / Prednisone regimenMustargen regimen with Oncovin, Procarbazine and Prednisone
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to MOPP regimen
Loading drug network...